André Baruchel

发表

miR-9 is a tumor suppressor in pediatric AML with t(8;21)

R. Pieters, M. Fornerod, M. D. Den Boer, 2014, Leukemia.

Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations

J. Soulier, E. Clappier, A. Baruchel, 2011, Leukemia.

High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome

M. D. Boer, R. Pieters, A. Baruchel, 2010, Leukemia.

Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE)

R. Scott, D. Hémon, A. Baruchel, 2012, Leukemia.

Unique BHLHB3 overexpression in pediatric acute myeloid leukemia with t(6;11)(q27;q23)

R. Stam, R. Pieters, A. Baruchel, 2014, Leukemia.

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements

C. Pui, N. Heerema, A. Baruchel, 2003, Leukemia.

High concordance of subtypes of childhood acute lymphoblastic leukemia within families: lessons from sibships with multiple cases of leukemia

C. Pui, R. Pieters, A. Baruchel, 2012, Leukemia.

In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia

A. Baruchel, H. Cavé, T. Blauwblomme, 2013, Leukemia.

Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup

J. Soulier, A. Baruchel, V. Najfeld, 2003, Leukemia.